Summary
8.34 -0.06(-0.66%)09/27/2024
Health Catalyst Inc (HCAT)
Health Catalyst Inc (HCAT)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -0.54 | -4.09 | 20.71 | 37.88 | 12.33 | -10.86 | -72.50 | -78.72 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 8.34 | |
| Open | 8.54 | |
| High | 8.63 | |
| Low | 8.25 | |
| Volume | 180,588 | |
| Change | -0.05 | |
| Change % | -0.54 | |
| Avg Volume (20 Days) | 469,956 | |
| Volume/Avg Volume (20 Days) Ratio | 0.38 | |
| 52 Week Range | 5.42 - 11.34 | |
| Price vs 52 Week High | -26.50% | |
| Price vs 52 Week Low | 53.78% | |
| Range | -2.40 | |
| Gap Up/Down | 0.12 | |
Fundamentals | ||
| Market Capitalization (Mln) | 507 | |
| EBIDTA | -39,332,000 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 61.82 | |
| Book Value | 10.5890 | |
| Earnings Per Share | -3.2640 | |
| EPS Estimate Current Quarter | -0.2200 | |
| EPS Estimate Next Quarter | -0.2000 | |
| EPS Estimate Current Year | -0.5000 | |
| EPS Estimate Next Year | -0.4400 | |
| Diluted EPS (TTM) | -3.2640 | |
| Revenues | ||
| Profit Marging | -0.6388 | |
| Operating Marging (TTM) | -0.4488 | |
| Return on asset (TTM) | -0.0913 | |
| Return on equity (TTM) | -0.3469 | |
| Revenue TTM | 230,488,992 | |
| Revenue per share TTM | 5.1100 | |
| Quarterly Revenue Growth (YOY) | 0.3080 | |
| Quarterly Earnings Growth (YOY) | 0.0000 | |
| Gross Profit (TTM) | 90,768,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 3.5183 | |
| Revenue Enterprise Value | 7.2853 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 52,055,300 | |
| Shares Float | 51,188,572 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 3.10 | |
| Institutions (%) | 106.03 | |
09/24 10:34 EST - seekingalpha.com
Health Catalyst: Still Optimistic On Achieving Adjusted EBITDA Targets
I recommend a buy rating for Health Catalyst stock. HCAT's Ignite platform is gaining traction, offering modular solutions that enhance adoption, cross-sell opportunities, and expand the total addressable market. Despite potential short-term ARPU concerns, Ignite's higher margins and ongoing migration will drive long-term profitability and significant upside by FY28.
Health Catalyst: Still Optimistic On Achieving Adjusted EBITDA Targets
I recommend a buy rating for Health Catalyst stock. HCAT's Ignite platform is gaining traction, offering modular solutions that enhance adoption, cross-sell opportunities, and expand the total addressable market. Despite potential short-term ARPU concerns, Ignite's higher margins and ongoing migration will drive long-term profitability and significant upside by FY28.
08/27 16:05 EST - globenewswire.com
Health Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences:
Health Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences:
08/27 08:00 EST - prnewswire.com
WISHIN Expands Relationship with Health Catalyst, Signing Multi-Year Partnership to Migrate to Ninja Universe™ Suite
SALT LAKE CITY , Aug. 27, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Wisconsin Statewide Health Information Network, Inc. (WISHIN), an independent not-for-profit organization dedicated to bringing the benefits of widespread, secure, interoperable health information technology to patients and caregivers throughout Wisconsin, has selected to expand its multi-year agreement with Health Catalyst. The multi-year arrangement will include migrating technology and services to Health Catalyst's Ninja Universe™ Suite, an end-to-end cloud-native platform, and a set of applications purpose-built for Health Information Exchanges (HIEs).
WISHIN Expands Relationship with Health Catalyst, Signing Multi-Year Partnership to Migrate to Ninja Universe™ Suite
SALT LAKE CITY , Aug. 27, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Wisconsin Statewide Health Information Network, Inc. (WISHIN), an independent not-for-profit organization dedicated to bringing the benefits of widespread, secure, interoperable health information technology to patients and caregivers throughout Wisconsin, has selected to expand its multi-year agreement with Health Catalyst. The multi-year arrangement will include migrating technology and services to Health Catalyst's Ninja Universe™ Suite, an end-to-end cloud-native platform, and a set of applications purpose-built for Health Information Exchanges (HIEs).
08/08 08:00 EST - prnewswire.com
Health Catalyst and South Dakota Health Link Expand Partnership to Improve the Quality and Effectiveness of Healthcare in the Midwest
SALT LAKE CITY , Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expanded relationship with longtime client, South Dakota Health Link ("Health Link"). This renewed agreement will include an expansion of technology and services, including the migration of technology to Ninja Universe by Health Catalyst™, an end-to-end cloud-native platform and set of applications purpose-built for Health Information Exchanges (HIEs).
Health Catalyst and South Dakota Health Link Expand Partnership to Improve the Quality and Effectiveness of Healthcare in the Midwest
SALT LAKE CITY , Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expanded relationship with longtime client, South Dakota Health Link ("Health Link"). This renewed agreement will include an expansion of technology and services, including the migration of technology to Ninja Universe by Health Catalyst™, an end-to-end cloud-native platform and set of applications purpose-built for Health Information Exchanges (HIEs).
08/08 08:00 EST - prnewswire.com
Health Catalyst Announces Partnership Expansion with Western U.S.'s Largest Health Information Exchange, Contexture
SALT LAKE CITY , Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expanded partnership with Contexture, a nonprofit, regional health information exchange organization that works to drive health data interoperability. Contexture supports the flow of health information between thousands of physician practices, hospitals, long-term care facilities, labs, radiology centers, and other healthcare organizations in Arizona and Colorado.
Health Catalyst Announces Partnership Expansion with Western U.S.'s Largest Health Information Exchange, Contexture
SALT LAKE CITY , Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expanded partnership with Contexture, a nonprofit, regional health information exchange organization that works to drive health data interoperability. Contexture supports the flow of health information between thousands of physician practices, hospitals, long-term care facilities, labs, radiology centers, and other healthcare organizations in Arizona and Colorado.
08/08 08:00 EST - prnewswire.com
Health Catalyst Finalizes Acquisition of Leading Care Management Company, Lumeon
SALT LAKE CITY , Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Lumeon Limited ("Lumeon"), a digital health company with operations in the U.S. and United Kingdom dedicated to helping provider organizations mend broken care coordination processes through automated care orchestration. Leading providers in the U.S. and the United Kingdom use Lumeon's Care Orchestration technology to lower costs, optimize clinician and staff time, enhance revenue, and improve quality and patient safety.
Health Catalyst Finalizes Acquisition of Leading Care Management Company, Lumeon
SALT LAKE CITY , Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Lumeon Limited ("Lumeon"), a digital health company with operations in the U.S. and United Kingdom dedicated to helping provider organizations mend broken care coordination processes through automated care orchestration. Leading providers in the U.S. and the United Kingdom use Lumeon's Care Orchestration technology to lower costs, optimize clinician and staff time, enhance revenue, and improve quality and patient safety.
08/07 22:39 EST - seekingalpha.com
Health Catalyst, Inc. (HCAT) Q2 2024 Earnings Call Transcript
Health Catalyst, Inc. (NASDAQ:HCAT ) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Jack Knight - VP, IR Dan Burton - CEO & Director Dan LeSueur - COO Jason Alger - CFO Conference Call Participants Stephanie Davis - Barclays Anne Samuel - JPMorgan Jared Haase - William Blair Sameer Patel - Evercore ISI Richard Close - Canaccord Genuity John Ransom - Raymond James Jessica Tassan - Piper Sandler Jenny Shen - BTIG Jack Wallace - Guggenheim Securities Stan Berenshteyn - Wells Fargo Jeff Garro - Stephens Operator Welcome to the Health Catalyst Second Quarter 2024 Earnings Conference Call. At this time all participants have been placed on a listen-only mode, and the floor will be open for your questions, following the presentation.
Health Catalyst, Inc. (HCAT) Q2 2024 Earnings Call Transcript
Health Catalyst, Inc. (NASDAQ:HCAT ) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Jack Knight - VP, IR Dan Burton - CEO & Director Dan LeSueur - COO Jason Alger - CFO Conference Call Participants Stephanie Davis - Barclays Anne Samuel - JPMorgan Jared Haase - William Blair Sameer Patel - Evercore ISI Richard Close - Canaccord Genuity John Ransom - Raymond James Jessica Tassan - Piper Sandler Jenny Shen - BTIG Jack Wallace - Guggenheim Securities Stan Berenshteyn - Wells Fargo Jeff Garro - Stephens Operator Welcome to the Health Catalyst Second Quarter 2024 Earnings Conference Call. At this time all participants have been placed on a listen-only mode, and the floor will be open for your questions, following the presentation.
08/07 20:36 EST - zacks.com
Health Catalyst (HCAT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Health Catalyst (HCAT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
08/07 20:05 EST - zacks.com
Health Catalyst (HCAT) Tops Q2 Earnings and Revenue Estimates
Health Catalyst (HCAT) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.05 per share a year ago.
Health Catalyst (HCAT) Tops Q2 Earnings and Revenue Estimates
Health Catalyst (HCAT) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.05 per share a year ago.
08/07 16:13 EST - globenewswire.com
Health Catalyst Reports Second Quarter 2024 Results
SALT LAKE CITY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2024.
Health Catalyst Reports Second Quarter 2024 Results
SALT LAKE CITY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2024.
07/18 09:00 EST - prnewswire.com
Health Catalyst Announces New Credit Facility for up to $225,000,000
SALT LAKE CITY , July 18, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company") (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has entered into a five-year term loan facility for up to $225,000,000 (the "Credit Facility" or the "Financing") with Silver Point Finance, the direct lending business of Silver Point Capital, L.P. The Financing consists of (i) an initial term loan facility in an aggregate principal amount of $125,000,000 (the "Initial Facility") and (ii) a delayed draw term loan facility (the "Delayed Draw Facility") in an aggregate principal amount of $100,000,000.
Health Catalyst Announces New Credit Facility for up to $225,000,000
SALT LAKE CITY , July 18, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company") (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has entered into a five-year term loan facility for up to $225,000,000 (the "Credit Facility" or the "Financing") with Silver Point Finance, the direct lending business of Silver Point Capital, L.P. The Financing consists of (i) an initial term loan facility in an aggregate principal amount of $125,000,000 (the "Initial Facility") and (ii) a delayed draw term loan facility (the "Delayed Draw Facility") in an aggregate principal amount of $100,000,000.
07/16 07:05 EST - investorplace.com
3 Overlooked Telehealth Stocks Poised for a Comeback
Healthcare portfolios include telehealth stocks, notably after the COVID-19 pandemic, which increased global telemedicine usage, demonstrating their importance for lockdowns and other social isolation scenarios. The worldwide telehealth market was $122.2 billion in 2023 and is anticipated to rise 28.4% annually from 2024 to 2032.
3 Overlooked Telehealth Stocks Poised for a Comeback
Healthcare portfolios include telehealth stocks, notably after the COVID-19 pandemic, which increased global telemedicine usage, demonstrating their importance for lockdowns and other social isolation scenarios. The worldwide telehealth market was $122.2 billion in 2023 and is anticipated to rise 28.4% annually from 2024 to 2032.
06/10 13:14 EST - benzinga.com
Time to Play 5 Top-Ranked Stocks With Rising P/E?
Wall Street has been hovering around a record high level, which can trigger overvaluation concerns in some investors' minds. This is because investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio.
Time to Play 5 Top-Ranked Stocks With Rising P/E?
Wall Street has been hovering around a record high level, which can trigger overvaluation concerns in some investors' minds. This is because investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio.
06/06 08:30 EST - prnewswire.com
Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive
SALT LAKE CITY , June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Carevive Systems ("Carevive"), a leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer. Oncology providers and life science researchers use Carevive's flagship platform and/or Carevive data in routine clinical practice for treatment care planning, clinical trial screening, care coordination, remote patient monitoring, and/or post-treatment care.
Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive
SALT LAKE CITY , June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Carevive Systems ("Carevive"), a leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer. Oncology providers and life science researchers use Carevive's flagship platform and/or Carevive data in routine clinical practice for treatment care planning, clinical trial screening, care coordination, remote patient monitoring, and/or post-treatment care.
05/28 12:26 EST - zacks.com
3 Medical Info Systems Stocks to Buy as GenAI Transforms Healthcare
Zacks Medical Info Systems industry stocks like Hims & Hers Health (HIMS), Enovis Corporation (ENOV) and Health Catalyst (HCAT) are expected to gain from the GenAI wave.
3 Medical Info Systems Stocks to Buy as GenAI Transforms Healthcare
Zacks Medical Info Systems industry stocks like Hims & Hers Health (HIMS), Enovis Corporation (ENOV) and Health Catalyst (HCAT) are expected to gain from the GenAI wave.
05/27 13:21 EST - zacks.com
Why Health Catalyst (HCAT) Might be Well Poised for a Surge
Health Catalyst (HCAT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Why Health Catalyst (HCAT) Might be Well Poised for a Surge
Health Catalyst (HCAT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
05/27 11:00 EST - zacks.com
Wall Street Analysts See a 75.19% Upside in Health Catalyst (HCAT): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 75.2% in Health Catalyst (HCAT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts See a 75.19% Upside in Health Catalyst (HCAT): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 75.2% in Health Catalyst (HCAT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
05/21 09:00 EST - prnewswire.com
Health Catalyst Unveils Next-Generation Data and Analytics Ecosystem Built for Healthcare, Health Catalyst Ignite®
SALT LAKE CITY , May 21, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of Health Catalyst Ignite® , a next-generation healthcare data and analytics ecosystem that combines best-in-class technologies, healthcare-specific data models, self-service tools, and industry expertise in one modern environment. Today's health systems face significant challenges in navigating a path to clinical, operational, and financial success.
Health Catalyst Unveils Next-Generation Data and Analytics Ecosystem Built for Healthcare, Health Catalyst Ignite®
SALT LAKE CITY , May 21, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of Health Catalyst Ignite® , a next-generation healthcare data and analytics ecosystem that combines best-in-class technologies, healthcare-specific data models, self-service tools, and industry expertise in one modern environment. Today's health systems face significant challenges in navigating a path to clinical, operational, and financial success.